The proto-oncogene product c-Myc can induce cell growth and proliferation. It regulates a large number of RNA polymerase II-transcribed genes, many of which encode ribosomal proteins, translation factors and other components of the biosynthetic apparatus. We have found that c-Myc can also activate transcription by RNA polymerases I and III, thereby stimulating production of rRNA and tRNA. As such, c-Myc may possess the unprecedented capacity to induce expression of all ribosomal components. This may explain its potent ability to drive cell growth, which depends on the accumulation of ribosomes. The activation of RNA polymerase II transcription by c-Myc is often inefficient, but its induction of rRNA and tRNA genes can be very strong in comparison.
Introduction
The proto-oncogene c-myc is essential for embryonic development, as shown by its targeted disruption in mice [1, 2] . Numerous biological activities have been attributed to its protein product, including the promotion of growth, cell cycle progression and apoptosis, as well as the suppression of differentiation 1 To whom correspondence should be addressed (email rwhite@udcf.gla.ac.uk) [3] [4] [5] [6] [7] [8] [9] [10] [11] . De-regulation of c-myc is associated with a broad range of cancer types [12] . For example, Burkitt's lymphomas are characterized by a chromosomal translocation that activates c-myc [12] . Overall, it has been estimated that c-Myc de-regulation contributes to one-seventh of all cancer deaths in the U.S.A. [5] .
Despite being one of the first oncogenes discovered and the subject of intense study, c-myc has been described as "an enduring enigma" [9] . There is no doubt that it encodes a DNA-binding factor that regulates gene transcription. However, there is an "apparent gap between Myc's biological role and what is surmised to be its molecular function" [9] . Long lists of Myc target genes have been identified, but in most cases the effect of Myc on expression of these genes is weak and variable [4, 9, 10] . Indeed, Eisenman [9] complained that alongside a "mountain of biological effects, the molecular characterization of Myc -as a relatively weak transcriptional regulator of uncertain target genes -looks like a molehill". It is therefore generally agreed that identifying bona fide targets remains a priority for Myc research.
Transcription by pol III (RNA polymerase III) is potently activated by c-Myc
Studies of Myc had concentrated until recently exclusively on its ability to regulate transcription of protein-encoding genes by pol II. However, we found that c-Myc functions as a direct and potent activator of pol III transcription [13] . When introduced by retroviral transduction, a hydroxytamoxifen-inducible Myc-ER (oestrogen receptor) fusion gene [14] will rapidly and specifically activate pol III-dependent expression of tRNA and 5 S rRNA genes in primary human diploid fibroblasts. Activation of tRNA genes by Myc typically reaches ∼12-fold or more and far exceeds that of the cyclin D2 gene, an established Myc target [14] , which is induced in parallel by 3.6-fold. These effects are specific, since control genes are not induced [13] . Further evidence of specificity came from the deletion of residues 106-143 within the Myc transactivation domain, which prevents induction of both tRNA and cyclin D2 [13] . This deletion removes the highly conserved MBII (Myc box II) sequence (residues 126-144), which is essential for cell transformation [15] .
The sets of genes that are induced by Myc overexpression can differ from those that respond to physiological levels of Myc [16] . However, the use of RNAi (RNA interference) and genetic knockouts showed that pol III transcription is extremely sensitive to endogenous c-Myc at physiological concentrations, in both human and rodent cells. Thus expression of pol III transcripts can be reduced by ∼7-fold in c-myc knockout fibroblasts, and restored by introduction of exogenous c-Myc [13] . Similarly, expression of tRNA and 5 S rRNA falls substantially if RNAi is used to deplete HeLa cells of endogenous c-Myc [17, 18] .
The timing of tRNA induction following activation of Myc-ER parallels that of the cyclin D2 gene, which is known to be a direct target of c-Myc [14] . Thus tRNA expression increases within 3 h, whereas S phase entry takes ∼17 h [14] . The alacrity of pol III activation suggests a direct effect of Myc.
This was confirmed using 2 µg/ml α-amanitin, which specifically blocks pol II transcription; any effect seen under these conditions cannot be a secondary response to induction of pol II-transcribed genes. Whereas α-amanitin prevented Myc activation of the cyclin D2 gene, expression of tRNA and 5 S rRNA was strongly induced [13] . This shows that c-Myc regulation of pol III templates does not require stimulation of protein-encoding genes. Unequivocal evidence of a direct effect came from ChIP (chromatin immunoprecipitation) studies, which showed that endogenous c-Myc associates with tRNA and 5 S rRNA genes in living fibroblasts and epithelial cells, but not with the pol II-transcribed control gene p21
Waf1 [13, 17] . Although ChIP assays show clearly that endogenous c-Myc binds to tRNA and 5 S rRNA genes in vivo, these genes do not contain good matches to the E-box DNA sequence that is recognized by Myc. Instead, c-Myc appears to be recruited to these genes by protein-protein interactions with the pol III-specific factor TFIIIB (transcription factor IIIB) [13] . In glutathione S-transferase pull-down assays, TFIIIB binds specifically to the c-Myc transactivation domain, which is required for tRNA induction in vivo [13] . Furthermore, co-immunoprecipitation and co-fractionation experiments show that endogenous c-Myc associates stably and specifically with endogenous TFIIIB [13] . We believe that it is TFIIIB, rather than a DNA sequence, that attracts c-Myc to pol III-transcribed genes.
Pol I transcription is also a direct target for activation by c-Myc
It had been reported previously that levels of large rRNA respond to Myc. It was found that accumulation of large rRNA is 2.3-fold lower in c-Myc knockout fibroblasts compared with wild-type controls [19] . Furthermore, the knockout cells are unable to accumulate rRNA following serum stimulation [20] . A 45% increase in rRNA was seen following overexpression of N-Myc in neuroblastoma cells [21] . However, these studies did not determine if such changes are due to direct effects of Myc on pol I transcription; they might instead reflect changes in rRNA processing or stability, as genes involved in rRNA maturation also respond to Myc [14, 16, [21] [22] [23] [24] [25] . Indeed, c-Myc has been shown to stimulate processing of the rRNA precursor transcript into mature 5.8, 18 and 28 S rRNA [25] . That study overlooked indications that the pre-rRNA primary transcript is itself induced by Myc [25] . However, several recent papers have confirmed that this is the case [18, [26] [27] [28] .
Northern blotting, pulse labelling and RT-PCR (reverse transcription-PCR) analyses revealed that expression of the rRNA precursor transcript increases in response to Myc-ER induction in fibroblasts of human, rat or mouse origin, as well as in mouse granulocytes [18, 26, 27] . Additional evidence of transcriptional induction was obtained using nuclear run-on assays with human B cells carrying a tetracycline-inducible c-Myc construct [18] . Activation of rRNA gene transcription by c-Myc is impervious to the presence of 2 µg/ml α-amanitin [18, 27] , which confirms that the response is not an indirect one that is mediated through regulation of pol II-transcribed genes encoding components of the pol I machinery. This is consistent with the rapidity of pre-rRNA induction, which is observed within 3 h of c-Myc activation [18] . Additional proof that the effect of c-Myc is direct in this case comes from ChIP assays that demonstrate its presence at rRNA gene loci within living HeLa and B cells [18, 27] . This is supported by immunofluorescence analyses of fibroblasts and COS-7 cells, which reveal the presence of c-Myc within nucleoli, the sites of pol I transcription in vivo [18, 27] . Furthermore, nucleolar c-Myc co-localizes with pre-rRNA, as shown by fluorescence in situ hybridization (FISH) [18] . These combined data confirm that c-Myc acts directly to stimulate pol I transcription of rRNA genes in a range of human and rodent cell types.
Many of the above experiments involved overexpression of c-Myc. However, a role for endogenous c-Myc in regulating rRNA synthesis at physiological concentrations was demonstrated by RNAi [18, 27] . Thus pol I transcription decreased significantly when siRNAs (small interfering RNAs) were used to reduce the concentration of endogenous c-Myc in the human cell lines U2OS and HeLa, as well as in primary human peripheral blood lymphocytes [18, 27] . This effect was not seen using control siRNAs against lamin, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) or luciferase [18, 27] . Furthermore, the transcriptional response could be rescued by co-transfecting mRNA encoding chicken c-Myc, which is not recognized by the siRNAs [27] . These data establish that the rate of pre-rRNA synthesis by pol I is sensitive to the availability of endogenous c-Myc.
In contrast with most pol III-transcribed genes, the rRNA gene repeats contain multiple copies of the E-box DNA sequence that is known to be recognized by Myc [18, 27] . Several are found within the vicinity of the promoter, a region that is occupied by c-Myc in both HeLa and B cells, as revealed by ChIP assays [18, 27] . In addition, c-Myc also binds in the vicinity of a dense cluster of E-boxes downstream of the 28 S rRNA coding region [18] . However, it remains to be determined whether the E-boxes are entirely responsible for c-Myc recruitment to these sites. An indication that protein-protein interactions may also contribute comes from the observation that a c-Myc mutant that is defective in DNA binding is nevertheless retained in nucleoli, albeit less efficiently than the wild-type protein [27] .
Genes for rRNA and tRNA are unusually good targets for activation by c-Myc
As mentioned in the Introduction, activation of pol II transcription by c-Myc is generally weak -typically less than 4-fold for most targets [4] . For example, Guo et al. [16] carried out a genomic screen with cDNA microarrays to identify genes that respond to c-Myc in Rat1 fibroblasts. They identified 96 protein-encoding genes that were consistently induced by >2-fold when c-Myc was restored to knockout cells and when wild-type cells were compared with the nulls; for these genes, the average induction was only 3.4-fold, and the strongest induction was 5.9-fold [16] . Coller et al. [14] used oligonucleotide microarray analysis to look for genes that were consistently induced when hydroxytamoxifen was added to primary human fibroblasts transduced with the Myc-ER construct. This approach identified 27 protein-encoding genes that were reproducibly induced by more than 2-fold; after averaging results from three identical experiments, the mean induction was 4.1-fold and the maximum was 8.9-fold [14] . Both of these studies used microarray approaches, but similar results have been obtained using other experimental techniques. For example, the gene for ODC (ornithine decarboxylase 1) is considered to be one of the best direct targets for c-Myc. In the microarray analysis by Coller et al. [14] , its average induction by Myc-ER in human fibroblasts was 5.9-fold. Greasley et al. [29] tested the same gene in Rat1 fibroblasts, using nuclear run-on and Northern blot approaches; in six experiments, their Northern analyses showed an average induction of 2.3-fold in response to Myc-ER, while their run-on assays revealed a maximum ODC induction of 2.8-fold. The same group obtained comparable results using RT-PCR [30] . This Laodicean response does not reflect some intrinsic property of the ODC gene, because it was induced by over 40-fold when serum was added to the same Rat1 cells [30] .
Using a combination of ChIP assays and high-density oligonucleotide arrays, it was estimated that the human genome may contain ∼25 000 sites that are bound by c-Myc in vivo [31] . This compares with ∼12 000 sites for Sp1 and 1600 sites for p53, as estimated using the same approach [31] . Of the ∼25 000 c-Myc-binding sites, ∼24% lie within CpG islands, which frequently encompass the promoter and first exon and intron of protein-encoding genes [31] . Indeed, 18% of the c-Myc sites were found within 1 kb of a gene's first exon [31] . Conversely, ∼11% of all pol II promoters are associated with a high-affinity Myc-binding site [32] . Greasely et al. [29] conducted a screen to look for Myc-responsiveness among genes that carry consensus E-boxes within a CpG island. Of 123 such genes, only 13 showed increased expression by Northern and/or nuclear run-on analyses when Myc-ER was induced in Rat1 cells [29] . For these 13 genes, the average induction was only 2.5-fold [29] . Occasional exceptions have been described. For example, Fernandez et al. [32] found a 43-fold induction in B cells of the TERT reverse transcriptase component of telomerase. Nevertheless, the consensus from many exhaustive studies makes it clear that the capacity of c-Myc to stimulate pol II transcription is "relatively wimpy" in most cases [9] . It was therefore striking that transcription by pols I and III shows very potent activation in similar assays. For example, induction of Myc-ER in primary human fibroblasts raised expression of pre-rRNA by 11-fold and expression of tRNA by 12-fold, after normalization against the mRNA for ARPP (acidic ribosomal phosphoprotein) P0 [13, 18] . For comparison, the same sets of samples were tested for activation of the pol II-transcribed cyclin D2 gene, one of the best characterized direct targets for c-Myc [14, 29, 33, 34] ; in this case, induction peaked at 3.6-fold ( Figure 1) .
As well as being extremely responsive to c-Myc overexpression, transcription by pols I and III is also very sensitive to levels of the endogenous protein. This is apparent in RNAi experiments, where partial depletion of endogenous c-Myc can cause a dramatic reduction in the expression of pre-rRNA and 5 S rRNA. When tested in parallel, cyclin D2 mRNA levels showed minimal change ( Figure 2 7SK RNA, which shows very little response. It is not yet clear why 7SK behaves differently in this respect, although it is known to be atypical in its promoter arrangement and transcription factor requirements [35] [36] [37] [38] .
Mechanisms of transcriptional activation by c-Myc
Most recent work on the mechanism(s) of transcriptional activation by c-Myc has focused on its ability to influence chromatin structure [4, 9, 39] . The N-terminal activation domain of c-Myc binds to the cofactor TRRAP (transformation/transactivation domain-associated protein) [40] , a 400 kDa member of the ATM (ataxia telangiectasia mutated) family that forms complexes with the HATs (histone acetyltransferases) GCN5, P/CAF (p300/ CBP-associated factor) and Tip60 [41, 42] . These interactions allow c-Myc to recruit HAT activity to E-box sites, leading to localized acetylation of histones H3 and H4 [30, 32, 34, 43] . Although there is a general correlation between histone acetylation and gene activation, there are cases in which transcriptional induction does not occur, despite a substantial increase in acetylated histones [30, 32] . For example, Myc-ER in Rat1 cells induces an ∼10-fold increase in histone H4 acetylation at the nucleolin gene without having any appreciable effect on its transcription [30] . This suggests that activation by c-Myc requires additional effects besides acetylation of histones. This might involve the remodelling of nucleosomes, since c-Myc has been shown to bind to the INI1/hSNF5 subunit of the SWI/SNF complex, as well as to the ATPase/helicases TIP48 and TIP49 [44, 45] . In addition, a direct interaction has been demonstrated between c-Myc and TBP (TATA-binding protein) [46] [47] [48] . Since TBP recruitment can be sufficient to activate transcription in vivo [49, 50] , this interaction provides a plausible mechanism by which c-Myc could regulate expression of some of its targets (Figure 3 ).
It will be interesting to determine whether the induction of pol I and pol III transcription by c-Myc involves novel mechanisms or conforms with the paradigms that have been established for pol II. Pol III may prove to be significantly different, since activation in this case appears to be independent of E-box motifs. The pol I situation seems much more familiar, in a number of respects. Here E-box sequences provide binding sites for c-Myc in the vicinity of the promoter, as well as elsewhere in the rRNA gene repeats [18, 27] . Furthermore, c-Myc induction provokes marked acetylation of histones H3 and H4 at these loci in U2OS and B cells [18, 27] . The increase in histone H4 acetylation is apparent around the rRNA gene promoter and termination sites, and is maximal ∼1 kb upstream of the transcription start site and negligible in parts of the intergenic spacer [18, 27] . However, H3 acetylation is much more localized, being strongly induced ∼1 kb upstream of the start, but not at the promoter itself [18] . The significance of these changes is unclear. Psoralen cross-linking experiments have shown that the fraction of rRNA genes in an accessible chromatin configuration changes little when pol I transcription is activated by serum stimulation of Friend cells, a situation in which c-Myc is likely to contribute substantially [51] . Furthermore, we found that efficient pol I induction by c-Myc can be reproduced in vitro using a naked DNA template [18] . Thus nuclear extracts prepared at various times after hydroxytamoxifen addition to Myc-ER-containing fibroblasts showed increased pol I transcriptional activity that began within 90 min of Myc induction and reached ∼14-fold after 7 h [18] . This robust activation in the absence of chromatin may be explained by the ability of c-Myc to bind to SL1, an essential component of the basal pol I machinery. SL1 binds to the rRNA gene promoter and is required for polymerase recruitment and transcription initiation [52] [53] [54] . Co-immunoprecipitation assays showed that it associates stably with endogenous c-Myc in human fibroblasts [18] . Pull-down assays further demonstrated that specific fragments of recombinant c-Myc can bind to an in vitro-translated SL1 subunit (TAF I 48, where TAF is TBP-associated factor), as well as native SL1 from HeLa cells [18] . Two distinct binding sites were detected: one in the C-terminal domain of c-Myc and the other within the MBII region of its transactivation domain [18] . The functional significance of the interaction between SL1 and c-Myc is suggested strongly by ChIP experiments, which demonstrate a substantial increase in SL1 occupancy of the rRNA gene promoter following induction of c-Myc in B cells [18] . On the basis of these observations, we suggest a model in which pol I transcriptional activation may be achieved by c-Myc binding to E-box sequences and recruiting SL1 to the promoter, thereby facilitating pre-initiation complex assembly. Histone acetylation accompanies this process, but its functional significance is unclear; it may assist rRNA gene activation in vivo, but is probably not essential, since robust induction can be mimicked in vitro in the absence of chromatin.
Components of the pol I and pol III transcription machinery can be induced by Myc
In addition to its direct effects on SL1 and TFIIIB, c-Myc can also augment a cell's capacity for rRNA and tRNA synthesis by activating class II genes encoding certain components of the pol I and pol III transcription machineries.
This was first demonstrated for the BN51 gene, which encodes a subunit of pol III [29] . The BN51 gene is occupied by endogenous c-Myc in a range of cell types, including human fibroblasts [32] . It contains a single consensus E-box within its first intron, a location favoured in many c-Myc targets [29] . A reporter consisting of the BN51 promoter, first exon and first intron fused to the luciferase coding region can be induced by 3-fold if c-Myc is transfected into Rat1 or 293T cells [29] . Conversely, repression was observed following transfection of the Myc antagonist Mad1 [29] . Substitution of the E-box (CACGTG→TACGTG) was sufficient to abolish these responses [29] . When the Myc-ER construct was induced by hydroxytamoxifen in Rat1 cells, transcription of the endogenous BN51 gene increased by 2.2-fold, as assessed by nuclear run-on, whereas Northern analysis showed a 2.5-fold increase in BN51 mRNA [29] . Although these data provide convincing evidence that the BN51 gene is regulated by c-Myc in some situations, it is not induced appreciably by Myc-ER in serum-starved primary human fibroblasts [13] ; perhaps in this case an alternative factor is limiting. Genetic data point to the significance of BN51 for cell proliferation, since a temperature-sensitive BN51 mutation that compromises pol III activity results in G 1 arrest at the non-permissive temperature in a hamster cell line [55] [56] [57] . Furthermore, G 1 arrest is also caused in Saccharomyces cerevisiae by a temperature-sensitive mutation in the yeast homologue of BN51 [58] . These observations led Greasley et al. [29] to speculate that reduced levels of pol III may contribute to the slow growth and proliferation and prolonged G 1 and G 2 phases of c-Myc knockout Rat1 cells.
As well as this key pol III subunit, c-Myc has also been shown to induce expression of the gene encoding the pol I transcription factor UBF (upstream binding factor) [26] . E-box sequences are present in the first intron and promoter of the UBF gene, as well as further upstream, and ChIP assays show the association of endogenous c-Myc with these regions in vivo [26] . Furthermore, induction of Myc-ER in NIH 3T3 cells causes a rapid 2.7-fold increase in UBF mRNA [26] . Mad1 binds to the same regions as c-Myc and can repress UBF expression [26] . Deletion of the distal E-boxes abrogated regulation of a transfected UBF reporter in response to c-Myc or Mad1 [26] . These data provide a convincing case for the UBF gene as a direct target for the Myc/Mad family. Regulation of UBF can have a substantial impact on the rate of pol I transcription [52, 53, [59] [60] [61] . UBF induction may therefore re-inforce the direct effect of c-Myc on SL1 to ensure high rates of rRNA synthesis. That this is the case in NIH 3T3 cells is suggested by the finding that the activation of pol I transcription by c-Myc can be attenuated by using a specific siRNA to prevent induction of UBF [26] .
In Drosophila, Myc induces genes encoding subunits of pols I and III, as well as the pol I-specific transcription factor TIF-IA (transcription intermediary factor-IA) [28] . Indeed, of the ten genes tested that encode components of the pol I or pol III machinery, eight were activated by Myc [28] . TIF-IA is believed to be a key control point in regulating pol I output that is conserved throughout evolution [52, 53, 61] . Overexpression of TIF-IA alone is sufficient to increase pre-rRNA expression in Drosophila imaginal wing discs [28] . Accordingly, Myc can stimulate pre-rRNA synthesis in wing discs and throughout third instar larvae, an effect that correlates with nucleolar expansion [28] . In contrast with mammalian systems, the induction in fruitflies seems to be entirely indirect. Thus Drosophila rRNA genes do not contain E-boxes and are not bound by Myc in vivo [28] . Instead, pol II transcription of genes encoding pol I and TIF-IA is induced prior to the increase in pre-rRNA expression [28] . This may suggest that indirect control of pol I output by Myc evolved prior to the direct effects seen in mammals; the appearance of E-boxes and binding to SL1 may have arisen subsequently, to accelerate and amplify the effect (Figure 4 ). There are precedents for this type of increase in complexity. For example, the insulin receptor/phosphoinositide 3-kinase pathway acts directly on the pol I machinery in mammals [62] [63] [64] , but not in fruitflies [28] .
Role of pols I and III in the biological function of c-Myc
The fruitfly model provides a clear indication of the importance of rRNA synthesis for the biological effects of Myc [28] . Induction of Myc in developing wing discs stimulates growth and leads to an increase in cell size [28, 65] . However, this effect can be substantially negated by using a pol I mutant to block any increase in rRNA expression [28] . Grewal et al. [28] concluded that "the growth effects of dMyc in larval wing imaginal discs require de novo rRNA synthesis". They went on to suggest that "during animal development, the control of rRNA synthesis and ribosome biogenesis is an essential Myc function".
Production of rRNA and tRNA is tightly coupled to the growth rate of cells [66, 67] . Under starvation conditions, rates of rRNA and tRNA synthesis decrease, whereas total mRNA production is sustained [68] [69] [70] . There is a strict inverse relationship between cell doubling time and nucleolar size, a cytohistological indicator of pol I activity [71, 72] . This is readily explained by the fact that growth (increase in mass) is directly proportional to the rate of protein accumulation [73] , which is inevitable, as 80-90% of cell mass is protein [74] . Activation of translation can increase cell size [75] . Furthermore, biosynthesis and the attainment of adequate mass are essential prerequisites for cell cycle progression [75] [76] [77] [78] [79] [80] [81] . Thus a 50% reduction in translation causes fibroblasts to exit the cell cycle and quiesce [82] [83] [84] . In most cell types, the mRNA concentration exceeds that of ribosomes, and so protein accumulation depends critically on ribosome content [85, 86] . As rRNA synthesis is a limiting step in ribosome production [87] , high output by pols I and III is essential for cells to maintain rapid growth. Thus hypertrophic growth of cardiomyocytes can be curtailed specifically by using an antisense vector against the pol I-specific factor UBF to restrict rRNA synthesis [88] . Conversely, specific activation of pol I transcription can accelerate the growth and proliferation of HEK293 cells [89] . Levels of tRNA can also have a major impact on growth rate; for example, a 2-fold reduction in levels of initiator tRNA causes a 3-fold increase in the doubling time of Saccharomyces cerevisiae [90] . In S. cerevisiae, mutations in pol I subunits were found to cause a substantial decrease in cell size [91] . The most potent effect on size was ascribed to Sfp1, a transcription factor that directly activates the genes encoding pols I and III, along with translation factors and various nucleolar components [91] . These observations link ribosome biogenesis directly to the commitment to cell division [81, 91] .
Activation of Myc drives a rapid increase in translation and growth, which precedes DNA replication and cell division [7, 92] . Indeed, Myc can stimulate growth and protein synthesis independently of cell cycle progression [16, 22, 24, 65, [93] [94] [95] . Conversely, loss of Myc diminishes growth and protein synthesis [7, 19, 65] . Many of the pol II-transcribed genes that respond to c-Myc are required for cell growth, including ribosomal proteins and translation initiation factors [11, 14, 16, [21] [22] [23] 32, 92, 96] . Our discovery that c-Myc can also stimulate synthesis of tRNA and rRNA by pols I and III suggests an unprecedented capacity to co-ordinately induce multiple components of the protein synthetic apparatus through parallel effects on independent transcription systems ( Figure  5 ). Since rRNA production can be rate-limiting for ribosome manufacture, protein accumulation and cell growth [61, 88, 89, 97] , the potent effect of c-Myc on rRNA synthesis may contribute substantially to its growth-promoting activity.
